Tuesday, December 06, 2016 2:53:46 PM
What they will find is that their DRUG Sucanon is the ONLY Type 2 DRUG with ZERO SIDE-EFFECTS.
What they will find is that the most prestigious HOSPITAL IN MEXICO just conducted a large clinical trial of the company's DRUG against Metformin (most proscribed Type 2 drug).
What they will find is a company whose DRUG was APPROVED in CANADA (not exactly a country known for approving fakes).
What they will find is a company whose DRUG is about to be APPROVED IN INDIA, with Canagen Pharma as the distributor.
What they will find is a company that has limited financial resources so capital is always an issue.
What they will find are LOYAL SHAREHOLDER (even DOCTORS!!) who understand and accept the risks.
It's not an investment for everybody, but if like me, you believe that sooner or later a DRUG that address the BIGGEST GLOBAL HEALTH CONCERN OF OUR TIMES AND HAS ZERO SIDE EFFECTS is going to be valuable at some point in the future, then it deserves a look.
FEATURED Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM
North Bay Resources Announces Mt. Vernon Gold Mine Bulk Sample, Sierra County, California • NBRI • Sep 11, 2024 9:15 AM
One World Products Issues Shareholder Update Letter • OWPC • Sep 11, 2024 7:27 AM
Kona Gold Beverage Inc. Reports $1.225 Million in Revenue and $133,000 Net Profit for the Quarter • KGKG • Sep 10, 2024 1:30 PM